Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bafna Pharmaceuticals Limited ( (IN:BAFNAPH) ) has shared an announcement.
Bafna Pharmaceuticals Limited announced the retirement of Mr. Palamadai Krishnan Sundaresan as an Independent Director, effective June 24, 2025. This change also affects his roles as Chairman of the Audit Committee and Member of the Nomination & Remuneration Committee. The company has reconstituted these committees with new appointments, ensuring continued compliance with applicable laws. This transition reflects Bafna Pharmaceuticals’ adaptability and commitment to maintaining strong governance structures.
More about Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited is a company operating in the pharmaceutical industry, focusing on the manufacturing and distribution of pharmaceutical products. The company is based in Chennai, Tamil Nadu, India, and is known for its commitment to quality and compliance with industry regulations.
Average Trading Volume: 1,035
Current Market Cap: 1.75B INR
Find detailed analytics on BAFNAPH stock on TipRanks’ Stock Analysis page.